Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children

This publication has 14 references indexed in Scilit:

• Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in Infancy
  New England Journal of Medicine, 1987
• Simultaneous Administration of Vaccines for Haemophilus influenzae type b, Pneumococci, and Meningococci
  The Journal of Infectious Diseases, 1986
• ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE
  The Lancet, 1985
• Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age
  The Journal of Pediatrics, 1985
• Adverse Reactions to Polyvalent Pneumococcal Vaccine
  Scandinavian Journal of Infectious Diseases, 1982
• Adverse reactions to pneumococcal polysaccharide vaccine in children
  The Pediatric Infectious Disease Journal, 1982
• Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future
  Immunochemistry, 1978
• Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in Finland
  The Journal of Infectious Diseases, 1977
• Present Status of Polysaccharide Vaccines in the Prevention of Meningococcal Disease
  Advances in Pediatrics, 1976
• Cutaneous Reactions and Antibody Response to Meningococcal Group C Polysaccharide Vaccines in Man
  The Journal of Infectious Diseases, 1970